# Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

> **NCT02047474** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 46 (actual)

## Conditions studied

- Acinar Cell Adenocarcinoma of the Pancreas
- Duct Cell Adenocarcinoma of the Pancreas
- Stage I Pancreatic Cancer
- Stage IIA Pancreatic Cancer
- Stage IIB Pancreatic Cancer

## Interventions

- **DRUG:** oxaliplatin
- **DRUG:** leucovorin calcium
- **DRUG:** irinotecan hydrochloride
- **DRUG:** fluorouracil
- **PROCEDURE:** therapeutic conventional surgery
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT02047474
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-25
- **Primary completion:** 2022-08-16
- **Final completion:** 2024-01-14
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02047474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02047474, "Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02047474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*